Cipla

Cipla Ltd. is an Indian multinational pharmaceutical company headquartered in Mumbai, founded in 1935. It is one of India’s largest and most respected drug manufacturers, with a strong presence across more than 80 countries and 47 manufacturing sites worldwide. Cipla develops, manufactures, and markets a wide range of pharmaceutical products, including branded and generic medicines, active pharmaceutical ingredients (APIs), biosimilars, diagnostics, and consumer healthcare products. The company is widely recognized for its humanitarian contributions, particularly for pioneering access to affordable HIV/AIDS treatments in developing countries by offering life-saving antiretroviral drugs at a fraction of global market prices. Over the years, Cipla has built a reputation for quality, innovation, and accessibility, with a portfolio spanning respiratory care, oncology, cardiovascular, anti-infectives, and more. Its growth is underpinned by strong research and development capabilities, a diversified product base, and a focus on sustainability and compliance in global healthcare.